金安國紀(002636.SZ)擬斥6億元投建年產3000萬張高等級覆銅板項目
格隆匯12月21日丨金安國紀(002636.SZ)宣佈,公司於2020年12月17日召開了第四屆董事會第二十四次會議,審議通過了《關於投資年產3000萬張高等級覆銅板項目的議案》,同意公司在安徽省寧國市投資新建“年產3000萬張高等級覆銅板項目”,該項目投資總額為6億元人民幣。
該項目選址為寧國市河瀝園區青山路以北、泰順路以西區域。項目預計2021年上半年開工建設,2022年上半年投產。項目所需資金來源為自籌資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.